GSEA revealed that several tumor hallmarks were enriched in the samples with high risk, such as epithelial-mesenchymal transition, inflammatory response, hypoxia, complement, IL2-STAT5 signaling, KRAS signaling (FDR < 0.05; Figure 8G) and so on. This evidence concerns the gene KRAS and neoplasm.